{"id":179798,"date":"2025-08-29T06:17:17","date_gmt":"2025-08-29T05:17:17","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/"},"modified":"2025-08-29T06:17:17","modified_gmt":"2025-08-29T05:17:17","slug":"impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/","title":{"rendered":"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1121.jpg\" \/><\/p>\n<p>El Servicio de Oncolog\u00eda del <a href=\"https:\/\/www.hospitalsonespases.es\/es\" target=\"_blank\" rel=\"noopener\">Hospital Universitario Son Espases<\/a> ha participado en un an\u00e1lisis retrospectivo del ensayo IMagyn050 sobre el impacto de a\u00f1adir el inhibidor del punto de control inmunitario atezolizumab en la quimioterapia de primera l\u00ednea sobre la supervivencia libre de progresi\u00f3n en el c\u00e1ncer de ovario de mal.<\/p>","protected":false},"excerpt":{"rendered":"<p>El Servicio de Oncolog\u00eda del Hospital Universitario Son Espases ha participado en un an\u00e1lisis retrospectivo del ensayo IMagyn050 sobre el impacto de a\u00f1adir el inhibidor del punto de control inmunitario atezolizumab en la quimioterapia de primera l\u00ednea sobre la supervivencia libre de progresi\u00f3n en el c\u00e1ncer de ovario de mal.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-179798","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario\" \/>\n<meta property=\"og:description\" content=\"El Servicio de Oncolog\u00eda del Hospital Universitario Son Espases ha participado en un an\u00e1lisis retrospectivo del ensayo IMagyn050 sobre el impacto de a\u00f1adir el inhibidor del punto de control inmunitario atezolizumab en la quimioterapia de primera l\u00ednea sobre la supervivencia libre de progresi\u00f3n en el c\u00e1ncer de ovario de mal.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T05:17:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1121.jpg\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario\",\"datePublished\":\"2025-08-29T05:17:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/\"},\"wordCount\":67,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1121.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/\",\"name\":\"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1121.jpg\",\"datePublished\":\"2025-08-29T05:17:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1121.jpg\",\"contentUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1121.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/","og_locale":"es_ES","og_type":"article","og_title":"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario","og_description":"El Servicio de Oncolog\u00eda del Hospital Universitario Son Espases ha participado en un an\u00e1lisis retrospectivo del ensayo IMagyn050 sobre el impacto de a\u00f1adir el inhibidor del punto de control inmunitario atezolizumab en la quimioterapia de primera l\u00ednea sobre la supervivencia libre de progresi\u00f3n en el c\u00e1ncer de ovario de mal.","og_url":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/","og_site_name":"bip4ex","article_published_time":"2025-08-29T05:17:17+00:00","og_image":[{"url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1121.jpg","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario","datePublished":"2025-08-29T05:17:17+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/"},"wordCount":67,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1121.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/","url":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/","name":"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1121.jpg","datePublished":"2025-08-29T05:17:17+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/#primaryimage","url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1121.jpg","contentUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1121.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/impacto-de-atezolizumab-en-la-supervivencia-del-cancer-de-ovario\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Impacto de atezolizumab en la supervivencia del c\u00e1ncer de ovario"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/179798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=179798"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/179798\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=179798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=179798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=179798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}